Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Digestive system drugs >  Antacid and Mucosal protective Drugs >  Bismuth subnitrate

Bismuth subnitrate

Basic information Safety Supplier Related

Bismuth subnitrate Basic information

Product Name:
Bismuth subnitrate
Synonyms:
  • Bismuth hydroxide nitrate oxide, Bi2O3 79% min
  • Bismuth(III) hydroxide nitrate, extra pure, Ph Eur, USP
  • BisMuth Subnitrate (AS)
  • Bismuth Subnitrate (1.5 g) (AS)
  • BISMUTH(III) NITRATE BASIC FOR ANALYSIS
  • BROMOTHYMOL BLUE SODIUM SALT INDICATOR W
  • Bismuth(Ⅲ) subnitrate
  • BisMuth(Ⅲ) nitrate basic
CAS:
1304-85-4
MF:
Bi5H9N4O22
MW:
1461.99
EINECS:
215-136-8
Product Categories:
  • Inorganics
Mol File:
1304-85-4.mol
More
Less

Bismuth subnitrate Chemical Properties

Melting point:
260°C
Density 
4.928
vapor pressure 
0Pa at 20℃
storage temp. 
Store at +5°C to +30°C.
solubility 
Practically insoluble in water and in ethanol (96 per cent). It dissolves in mineral acids with decomposition.
form 
Powder/Solid
color 
White
PH
3.2 (50g/l, H2O, 20℃)(slurry)
Water Solubility 
Practically insoluble in water and alcohol. Soluble in dilute HNO{3} and HCl
Sensitive 
Hygroscopic
Merck 
14,1284
Stability:
Stability Strong oxidizer - contact with combustible material may lead to fire. Incompatible with reducing agents, organic materials.
CAS DataBase Reference
1304-85-4(CAS DataBase Reference)
EPA Substance Registry System
Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) (1304-85-4)
More
Less

Safety Information

Hazard Codes 
O,Xi
Risk Statements 
8-36/37/38
Safety Statements 
17-26-36/37/39-36
RIDADR 
UN 1477 5.1/PG 2
WGK Germany 
3
RTECS 
EB2977000
8
TSCA 
Yes
HS Code 
2834 29 80
HazardClass 
5.1
PackingGroup 
II
Hazardous Substances Data
1304-85-4(Hazardous Substances Data)
Toxicity
infant,LDLo,oral,1gm/kg (1000mg/kg),"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 134, 1969.

MSDS

More
Less

Bismuth subnitrate Usage And Synthesis

Description

Bismuth subnitrate, also referred to as bismuth oxynitrate or bismuthyl nitrate, is a highly water-soluble crystalline compound that has been used as a treatment for duodenal ulcers and anti-diarrheic agent. The use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA.

Bismuth Subnitrate is a basic salt that contains the equivalent of not less than 79.0 percent of bismuth trioxide (Bi2O3),calculated on the dried basis.It is both odorless and tasteless, and is used in bleaching and freckle creams, and hair dyes.
Bismuth subnitrate has been used to induce metallothionein in heart tissue and kidneys and to attenuate the toxicity of Adriamycin and cisplatin compounds, respectively.

Chemical Properties

White, heavy, Slightly hygroscopic powder

Uses

manufacture of bismuth fluxes for enamels; in cosmetics.

Uses

Bismuth subnitrate (BiNO3) is used in the cosmetics industry and to make ceramic and enamel glazes.

Uses

It is used pharmaceutically in wound dressing, ointment component and as an antiacid. In cosmetics it is used as a cosmetic white pigment. Used in Ceramic glazes and enamel fluxes.

brand name

Mammol (Abbott).

Flammability and Explosibility

Non flammable

Pharmacology

Bismuth subnitrate acts as an antacid that exert protective effects on the gastric mucosa. In a double-blind endoscopically controlled study, bismuth substrate was demonstrated to be effective for symptomatic relief in duodenal ulcers. In the alcohol model of mucosal injury in the rat, bismuth substrate was shown to be cytoprotective. In a randomized clinical study consisting of patients with H. pylori-associated duodenal ulcer, adjunctive use of colloidal bismuth subnitrate in a short treatment regimen with omeprazole and clarithromycin resulted in improved eradication rate of H. pylori.

Mode of action

Based on the findings of a clinical investigation in patients with duodenal ulcer disease and healthy volunteers receiving oral bismuth subnitrate tablets, the protective effects of bismuth subnitrate may be secondary to endogenous mucosal prostaglandin (PGE2) production, which is one of the deficient factors observed in peptic ulcer disease. Antacid neutralizing activity of bismuth subnitrate was demonstrated to have a significant postprandial effect on gastric pH.

Bismuth subnitrateSupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Beijing Ouhe Technology Co., Ltd
Tel
010-82967028 13552068683
Email
2355560935@qq.com